Dymista nasal spray launched in U.K pharmacies in 2025. For moderate to severe allergic rhinitis, it offers rapid relief by addressing both the antihistamine and anti-inflammatory effects of an allergic reaction. An entire campaign was created and launched across multi-media platforms, in-store point of sale and HCP (Healthcare Professional) product visual aids.
